Grifols

Grifols EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Grifols (GRF.MC) as of Nov 2, 2026 is 6.19 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 5.35 % — a change of 15.70% (higher).

EBIT/Assets

6.19 %

YoY

15.70%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Grifols is 2025 6.19 % . Operating Income to Assets Ratio (EBIT/Assets) of Grifols was 2024 5.35 % . It decreases by 15.70% higher compared to the previous year.

The Grifols EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
7.97 EUR
Jan 1, 2019
7.34 EUR
Jan 1, 2020
6.52 EUR
Jan 1, 2021
3.09 EUR
Jan 1, 2022
3.74 EUR
Jan 1, 2023
3.44 EUR
Jan 1, 2024
5.35 EUR
Jan 1, 2025
6.19 EUR
The Grifols EBIT/Assets history
YEAREBIT/AssetsYoY
6.19 %+15.70%
5.35 %+55.44%
3.44 %-8.01%
3.74 %+20.93%
3.09 %-52.56%
6.52 %-11.20%
7.34 %-7.82%
7.97 %-10.76%
8.93 %-3.73%
9.27 %-8.24%
10.11 %-0.44%
10.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

Operating Income to Assets Ratio (EBIT/Assets) of Grifols is 6.19 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Grifols changed from 5.35 % to 6.19 %, representing a 15.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Grifols since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Grifols with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Grifols

All Key Metrics — Grifols